Objective:This study aimed to comprehensively evaluate the clinical efficacy, surgical precision, and postoperative outcomes of robotic-assisted surgery in the management of pediatric urological conditions.Methodology:A retrospective cohort study was conducted, encompassing 150 pediatric patients who underwent robotic-assisted urological surgery, with a comparative cohort of 120 patients who received conventional laparoscopic or open interventions. Data were meticulously extracted from electronic medical records and institutional surgical registries, encompassing demographic characteristics, intraoperative metrics, postoperative recovery indicators, and long-term functional outcomes. Advanced statistical analyses, including paired t-tests, chi-square tests, multivariate regression models, and Kaplan-Meier survival analysis, were utilized to assess operative time, intraoperative blood loss, complication rates, recurrence-free survival, and overall surgical success. Furthermore, qualitative insights from patient and caregiver satisfaction surveys were analyzed to gauge perceived pain reduction, cosmetic outcomes, and postoperative quality of life improvements.Results:The study findings unequivocally demonstrated the clinical and perioperative superiority of robotic-assisted surgery over conventional approaches. Mean operative time was reduced by 20 minutes in RAS cases, while estimated intraoperative blood loss was nearly 50% lower compared to traditional surgical modalities, affirming the precision and minimally invasive nature of robotic interventions. Postoperative recovery metrics revealed that patients in the RAS cohort exhibited significantly shorter hospitalization durations (2.1 days vs. 4.5 days), accelerated return to oral intake (12 hours vs. 20 hours), and markedly lower postoperative pain scores (3.2 vs. 5.8 on a 10-point scale). The incidence of postoperative complications, including urinary tract infections (5% vs. 10%), anastomotic strictures (2% vs. 6%), and wound infections (1% vs. 4%), was substantially lower in the RAS group. Long-term functional assessments indicated enhanced renal function preservation (85% vs. 78%), higher resolution rates of hydronephrosis (90% vs. 82%), and improved urinary continence outcomes (95% vs. 88%) in robotic-assisted procedures. Patient and caregiver satisfaction indices were significantly elevated, with 93% of caregivers expressing high satisfaction and 85% demonstrating a strong preference for robotic-assisted interventions in future surgical procedures.Conclusion:This study reinforced the transformative role of robotic-assisted surgery in pediatric urology, demonstrating unparalleled intraoperative control, reduced perioperative morbidity, and superior long-term surgical outcomes compared to conventional approaches. The findings substantiated the growing preference for RAS due to its minimally invasive execution, expedited recovery trajectories, and enhanced postoperative quality of life. Despite economic and infrastructural barriers to widespread adoption, advancements in robotic technology, artificial intelligence-enhanced surgical navigation, and immersive simulation-based training are anticipated to broaden accessibility and standardization in pediatric robotic-assisted interventions. These results advocate for the integration of RAS as a cornerstone of pediatric urological surgical practice, laying the foundation for future innovations in minimally invasive pediatric surgery.